Share ideas that matter on the social web and experience
the benefits of curating the world's best content.
I don't have a Facebook, a Twitter or a LinkedIn account
|
Scooped by Ellen H Ullman, MSW onto diabetes and more |
Scoop.it!
DES MOINES, Iowa — IndyCar driver Charlie Kimball found it more than humbling to be honored with a group that included an 11-year-old Texas boy who started a city-wide recycling program and a Baltimore woman who founded a nonprofit program to help...
Are you sure you want to delete this scoop?
 Your new post is loading...
Scoop.it!
Delete the scoop?
Are you sure you want to delete this scoop?
Yes
Scoop.it!
Ellen H Ullman, MSW's insight:
George S. Eisenbarth, MD, PhD, could be considered a natural conduit in the research of type 1 diabetes (T1D) and the fields of endocrinology and immunology. His recognition of T1D as a chronic autoimmune disease has advanced the field toward prediction, prevention, and clinical trials. His focus on insulin as the key autoantigen in islet autoimmunity unraveled the molecular basis of the insulin autoimmune response, leading to experimental antigen-specific therapies that are presently approaching clinical translation and represent a model approach for the treatment of human T1D and other autoimmune diseases. Delete the scoop?
Are you sure you want to delete this scoop?
Yes
Scoop.it!
In this episode of the Edelman Report, Dr. Edelman discusses Incretins and Type 1's? Delete the scoop?
Are you sure you want to delete this scoop?
Yes
Scoop.it!
25 May 2013 - United States - Employment and HR - EEOC Issues Updated Publications on Specific Disabilities - Day Pitney LLP - The EEOC recently issued four revised documents in its disability discrimination Questions and Answers Series, addressing... Delete the scoop?
Are you sure you want to delete this scoop?
Yes
Scoop.it!
The EMA (European Medicines Agency) has released draft guidelines on biosimilars allowing non-EEA comparators to be used in limited circumstances. Delete the scoop?
Are you sure you want to delete this scoop?
Yes
Scoop.it!
A bill passed by the Florida legislature would allow pharmacists to substitute biosimilars for brand-name biologics provided that a number of criteria are met. Delete the scoop?
Are you sure you want to delete this scoop?
Yes
Scoop.it!
PHILADELPHIA, May 23, 2013 /PRNewswire/ -- Echo Therapeutics, Inc. (Nasdaq: ECTE), a company developing its... Delete the scoop?
Are you sure you want to delete this scoop?
Yes
Scoop.it!
Tanzania\'s leading online News Edition (The National Newspaper). Delete the scoop?
Are you sure you want to delete this scoop?
Yes
Scoop.it!
DRI tv is an exciting, new way to learn about the research breakthroughs at the Diabetes Research Institute, including the DRI BioHub. Delete the scoop?
Are you sure you want to delete this scoop?
Yes
Scoop.it!
Can oral insulin succeed where other alternative delivery methods have failed? Dan Stanton, from in-Pharmatechnologist.com assesses its chances. Delete the scoop?
Are you sure you want to delete this scoop?
Yes
Scoop.it!
I am motivated to take care of my diabetes on a daily basis: I feel good when my blood sugars are in-range. I want to be healthy enough to support the people a Delete the scoop?
Are you sure you want to delete this scoop?
Yes
Scoop.it!
Echo Therapeutics, Inc., a company developing its needle-free Symphony CGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system, announced today that the Company's clinical trial of its Symphony CGM System has... Delete the scoop?
Are you sure you want to delete this scoop?
Yes
|
Scoop.it!
Delete the scoop?
Are you sure you want to delete this scoop?
Yes
Scoop.it!
A Johns Hopkins scientist has issued a blistering report on influenza vaccines in the British Medical Journal (BMJ). Delete the scoop?
Are you sure you want to delete this scoop?
Yes
Scoop.it!
California Supreme Court to review whether unlicensed school employees can give insulin to diabetic students; nurses say it would jeopardize student safety. Delete the scoop?
Are you sure you want to delete this scoop?
Yes
Scoop.it!
The patent battle between US pharmaceuticals major Merck Sharp and Dohme (MSD) and Indian firm Glenmark Pharmaceuticals over the sale of diabetes drug Januvia comes up for hearing in the Delhi High Court on Thursday. 
Mark Chataway's curator insight,
Today, 11:33 AM
MSD had done the right thing here: the medicine in India cost about 20% of what it cost in Western markets. MSD had also licensed an Indian brand of the drug. If thisthe Court tolerates this kind of treatment of comapnies which use responsible pricing, don't expect many others to try it Delete the scoop?
Are you sure you want to delete this scoop?
Yes
Scoop.it!
Disney has gotten a lot of backlash from the Celiac community for standing up for what we believe in, standing up for what we think is right, and standing up for our kids sakes. If you haven’t heard... Delete the scoop?
Are you sure you want to delete this scoop?
Yes
Scoop.it!
Researchers are launching a large-scale comparative effectiveness trial that will help determine which of the top type 2 diabetes drugs are best for glycemic control. Delete the scoop?
Are you sure you want to delete this scoop?
Yes
Scoop.it!
In this study, using high-throughput sequencing techniques, scientists sought to identify new variants, including rare and potentially high risk ones, in 25 previously identified risk genes in a sample of nearly 42,000 individuals. Delete the scoop?
Are you sure you want to delete this scoop?
Yes
Scoop.it!
Abbott has received EU approval for its new Architect Hemoglobin A1c (HbA1c) assay, a simple blood test designed to aid the diagnosis and monitoring of diabetes. Delete the scoop?
Are you sure you want to delete this scoop?
Yes
Scoop.it!
In 1988, I became extremely ill. I had many tests, saw many doctors and was given various medicines. Some caused allergic reactions. Through it all, I remained sick — and actually became worse. Delete the scoop?
Are you sure you want to delete this scoop?
Yes
Ellen H Ullman, MSW's comment,
May 21, 9:49 PM
Shouldn't this be FREE to read? They are charging approximately $180 US for lay persons to read about meter standards for lay persons use!
Delete the scoop?
Are you sure you want to delete this scoop?
Yes
|
